The activation of the TLR4 signaling pathway induces TNF-α and NF-κB, leading to the promotion of CRC (17, 54–56); TNF-α knockout mice treated with AOM/DSS show significantly less tumor formation, representing the pro-tumorigenic role of TNF-α (57). The gene discussed is TLR4; the disease is colorectal carcinoma.